SHANGHAI, Nov 12 (Reuters) – China has approved Eli Lilly’s weight loss pill orforglipron, the country’s medicine regulator said on Thursday.
(Reporting by Andrew Silver; additional reporting from Beijing newsroom; Editing by Christian Schmollinger)
Comments